Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade | Neuropsychopharmacology
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking | PNAS
Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice - ScienceDirect
IJMS | Free Full-Text | Molecular Mechanisms of Neurogenic Inflammation of the Skin
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Non-nociceptive roles of opioids in the CNS: opioids' effects on neurogenesis, learning, memory and affect | Nature Reviews Neuroscience
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice - ScienceDirect
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking | PNAS
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants | Chemical Reviews
Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor | PNAS
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Activation of the nociceptin/orphanin-FQ receptor promotes NREM sleep and EEG slow wave activity | PNAS
Probing the Activation Mechanisms of Agonist DPI-287 to Delta-Opioid Receptor and Novel Agonists Using Ensemble-Based Virtual Screening with Molecular Dynamics Simulations | ACS Omega
The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies | Current Addiction Reports
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking | PNAS
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
An Interactive Voice Response dialogue. The Voice User Interface (VUI)... | Download Scientific Diagram
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease - Gasparotto - Journal of Neurochemistry - Wiley Online Library
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice - ScienceDirect
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5′-guanidinonaltrindole and the biased kappa opioid receptor agonist 6′-guanidinonaltrindole in mice - ScienceDirect
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice - ScienceDirect
Effects of the mu-opioid receptor agonist morphine on facial mimicry and emotion recognition - ScienceDirect
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking | PNAS
The role of the opioid system in decision making and cognitive control: A review | Cognitive, Affective, & Behavioral Neuroscience
